These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 25925701
41. The safety of intravenous iron sucrose use in the elderly patient. Reed J, Charytan C, Yee J. Consult Pharm; 2007 Mar; 22(3):230-8. PubMed ID: 17658969 [Abstract] [Full Text] [Related]
42. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Li H, Wang SX. Perit Dial Int; 2008 Mar; 28(2):149-54. PubMed ID: 18332450 [Abstract] [Full Text] [Related]
43. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Hetzel D, Strauss W, Bernard K, Li Z, Urboniene A, Allen LF. Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149 [Abstract] [Full Text] [Related]
44. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J. Aliment Pharmacol Ther; 2019 Aug; 50(4):397-406. PubMed ID: 31264261 [Abstract] [Full Text] [Related]
47. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Goldstein SL, Morris D, Warady BA. Am J Kidney Dis; 2013 Apr; 61(4):588-97. PubMed ID: 23245582 [Abstract] [Full Text] [Related]
48. Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Auerbach M, Achebe MM, Thomsen LL, Derman RJ. Obes Surg; 2022 Mar; 32(3):810-818. PubMed ID: 35000068 [Abstract] [Full Text] [Related]
49. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C, FERGI Study Group. Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794 [Abstract] [Full Text] [Related]
50. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. Kochhar PK, Kaundal A, Ghosh P. J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176 [Abstract] [Full Text] [Related]
51. Iron (III) isomaltoside 1000. Mace TA, Syed A, Bhandari S. Expert Rev Hematol; 2013 Jun; 6(3):239-46. PubMed ID: 23782077 [Abstract] [Full Text] [Related]
53. Perioperative changes in haemoglobin and ferritin concentrations from preoperative intravenous iron isomaltoside for iron deficiency anaemia in patients with colorectal cancer: A pilot randomised controlled trial. Fung PLP, Lau VNM, Ng FF, Leung WW, Mak TWC, Lee A. PLoS One; 2022 Mar; 17(6):e0270640. PubMed ID: 35771891 [Abstract] [Full Text] [Related]
54. Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients. Sharma J, Tiwari S. JNMA J Nepal Med Assoc; 2015 Mar; 53(198):104-7. PubMed ID: 26994029 [Abstract] [Full Text] [Related]
56. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894 [Abstract] [Full Text] [Related]
57. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment. Pollock RF, Muduma G. Expert Rev Hematol; 2019 Feb; 12(2):129-136. PubMed ID: 30689458 [Abstract] [Full Text] [Related]
58. A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China. Jin J, Ran Z, Noseda E, Roubert B, Marty M, Mezzacasa A, Göring UM. Front Med; 2024 Feb; 18(1):98-108. PubMed ID: 37897561 [Abstract] [Full Text] [Related]
59. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, Iftikhar H, Mangoo-Karim R, Martin ER, Martinez CO, Newman GE, Qunibi WY, Ross DL, Singh B, Smith MT, Butcher A, Koch TA, Goodnough LT. Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731 [Abstract] [Full Text] [Related]
60. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. Wall GC, Pauly RA. Am J Health Syst Pharm; 2008 Jan 15; 65(2):150-3. PubMed ID: 18192261 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]